Comparison between ANB Metal Cast IPO and Asston Pharmaceuticals IPO.
ANB Metal Cast IPO is a SME Bookbuilding IPO proposed to list at NSE SME while Asston Pharmaceuticals IPO is a SME Bookbuilding proposed to list at BSE SME.
| ANB Metal Cast IPO | Asston Pharmaceuticals IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Bookbuilding | Bookbuilding |
| Listing At | NSE SME | BSE SME |
| Lead Managers | Sun Capital Advisory Services Pvt.Ltd. | Sobhagya Capital Options Pvt.Ltd. |
| Registrar | Kfin Technologies Ltd. | Maashitla Securities Pvt.Ltd. |
| Market Maker | Pure Broking Pvt.Ltd. | JSK Securities & Services Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Anchor Investor | Anchor Investor | Anchor Investor |
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of ANB Metal Cast IPO is up to ₹46.80 Cr whereas the issue size of the Asston Pharmaceuticals IPO is up to ₹26.17 Cr. The final issue price of ANB Metal Cast IPO is ₹156.00 per share and of Asston Pharmaceuticals IPO is ₹123.00 per share.
| ANB Metal Cast IPO | Asston Pharmaceuticals IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ₹148.00 per share | ₹115.00 per share |
| Issue Price (Upper) | ₹156.00 per share | ₹123.00 per share |
| Issue Price (Final) | ₹156.00 per share | ₹123.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ||
| Market Lot Size | 800 shares | 1000 shares |
| Fresh Issue Size | 30,00,000 shares | 21,28,000 shares |
| Fresh Issue Size (Amount) | up to ₹46.80 Cr | up to ₹26.17 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 30,00,000 shares | 21,28,000 shares |
| Issue Size Total (Amount) | up to ₹46.80 Cr | up to ₹26.17 Cr |
ANB Metal Cast IPO opens on Aug 08, 2025, while Asston Pharmaceuticals IPO opens on Jul 09, 2025. The closing date of ANB Metal Cast IPO and Asston Pharmaceuticals IPO is Aug 12, 2025, and Jul 11, 2025, respectively.
| ANB Metal Cast IPO | Asston Pharmaceuticals IPO | |
|---|---|---|
| Anchor Bid Date | Aug 07, 2025 | Jul 08, 2025 |
| Issue Open | Aug 08, 2025 | Jul 09, 2025 |
| Issue Close | Aug 12, 2025 | Jul 11, 2025 |
| Basis Of Allotment (Tentative) | Aug 13, 2025 | Jul 14, 2025 |
| Initiation of Refunds (Tentative) | Aug 14, 2025 | Jul 15, 2025 |
| Credit of Share (Tentative) | Aug 14, 2025 | Jul 15, 2025 |
| Listing date (Tentative) | Aug 18, 2025 | Jul 16, 2025 |
| Anchor Lockin End date 1 | Sep 12, 2025 | Aug 13, 2025 |
| Anchor Lockin End date 2 | Nov 11, 2025 | Oct 12, 2025 |
ANB Metal Cast IPO P/E ratio is 13.15, as compared to Asston Pharmaceuticals IPO P/E ratio of 17.83.
| ANB Metal Cast IPO | Asston Pharmaceuticals IPO | ||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | EBITDA | Asston Pharmaceuticals Limited Financial Information (Restated)Asston Pharmaceuticals Limited's revenue increased by 62% and profit after tax (PAT) rose by 218% between the financial year ending with March 31, 2025 and March 31, 2024.
| |||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 91.49 | 68.76 | |||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 66.75 | 50.66 | |||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 13.15 | 17.83 | |||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹184.62 Cr. | ₹104.70 Cr. | |||||||||||||||||||||||||||||||||||||||||||||
| ROE | 45.91% | 50.56% | |||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 24.13% | 51.25% | |||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 1.01 | 0.68 | |||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹11.87 | ₹6.90 | |||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 45.91% | 40.36% | |||||||||||||||||||||||||||||||||||||||||||||
In the ANB Metal Cast IPO Retail Individual Investors (RII) are offered 10,51,200 shares while in Asston Pharmaceuticals IPO retail investors are offered 10,51,200 shares. Qualified Institutional Buyers (QIB) are offered 5,99,200 shares in ANB Metal Cast IPO and 4,25,000 shares in Asston Pharmaceuticals IPO.
| ANB Metal Cast IPO | Asston Pharmaceuticals IPO | |
|---|---|---|
| Anchor Investor Reserveration | 8,98,400 shares | 6,35,000 shares |
| Market Maker Reserveration | 2,00,000 shares | 1,13,000 shares |
| QIB | 5,99,200 shares | 4,25,000 shares |
| NII | 4,51,200 shares | 3,22,000 shares |
| RII | 10,51,200 shares | 7,46,000 shares |
| Employee | 0 shares | 0 shares |
| Others | ||
| Total | 30,00,000 shares | 21,28,000 shares |
ANB Metal Cast IPO subscribed 2.22x in total, whereas Asston Pharmaceuticals IPO subscribed 186.55x.
| ANB Metal Cast IPO | Asston Pharmaceuticals IPO | |
|---|---|---|
| QIB (times) | 1.04x | 85.76x |
| NII (times) | 4.29x | 353.14x |
| Big NII (times) | 6.29x | 424.47x |
| Small NII (times) | 2.96x | 210.85x |
| RII (times) | 2.39x | 172.06x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 2.22x | 186.55x |
Free Equity Delivery
Flat ₹10 per Trade in Intraday & F&O
